Equities

JZJ Chain Drugstore Corp

605266:SHH

JZJ Chain Drugstore Corp

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (CNY)20.52
  • Today's Change-0.05 / -0.24%
  • Shares traded1.52m
  • 1 Year change-55.95%
  • Beta1.3443
Data delayed at least 15 minutes, as of Jul 26 2024 08:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

JZJ Chain Drugstore Corp is a China-based company principally engaged in chain retail business. The Company operates primarily through two segments. The Pharmaceutical Retail segment is mainly engaged in the retail of Chinese medicinal materials, health foods, personal care products, home health products and medical equipment. The Convenience Retail segment is mainly engaged in the sales of convenience products such as convenience foods and daily consumables. The Company is also engaged in the provision of professional services to pharmaceutical and convenience providers, as well as the provision of physical examination services to patients. The Company principally conducts its businesses in the domestic market.

  • Revenue in CNY (TTM)9.23bn
  • Net income in CNY390.37m
  • Incorporated2004
  • Employees16.65k
  • Location
    JZJ Chain Drugstore CorpComplex BuildingWanhong Jiayuan Fengyuan (Plot 5), LianmWanhong Road Intersection, Panlong DistrKUNMING 650224ChinaCHN
  • Phone+86 87 165711920
  • Fax+86 87 165711330
  • Websitehttps://www.jzj.cn/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sunshine Holdings PLC1.33bn106.98m718.06m1.70k6.711.594.350.54049.099.09112.8838.431.403.496.2832,609,450.0015.1512.8727.7823.7431.0429.6910.8410.291.0514.670.299116.937.0319.6597.4947.20-5.6948.41
Medical System Network Co Ltd5.44bn87.78m799.30m3.74k8.961.073.360.146961.7561.753,836.48519.081.7212.5030.1630,812,230.002.792.194.173.3541.5440.831.621.330.656313.490.657223.755.303.2715.5332.12-7.853.71
Charmacy Pharmaceutical Co Ltd4.42bn51.48m803.50m831.0015.611.3410.300.1820.51320.513244.025.981.446.054.885,720,877.001.681.798.287.996.346.081.171.240.77752.790.511137.095.472.27-43.252.48-16.010.0027
Dingdang Health Technology Group Ltd4.87bn-226.42m1.20bn2.62k--0.5855--0.2456-0.1821-0.18213.921.641.535.4844.372,005,079.00-7.26-55.91-10.34-82.5131.1032.74-4.75-35.831.93--0.0644--12.1952.7292.03--13.40--
Kimia Farma Tbk PT4.54bn-690.23m1.51bn11.18k--0.6022--0.333-278.91-285.741,832.811,013.040.54332.494.98889,725,100.00-10.39-1.82-21.12-3.2228.0235.14-19.12-3.080.3249-2.700.5505--7.933.33-737.71---9.87--
JZJ Chain Drugstore Corp9.23bn390.37m3.22bn16.65k8.111.09--0.34852.532.5359.7218.890.94572.5117.64554,255.804.015.757.3811.1735.8335.214.245.040.3124.420.618636.6220.8426.8410.7225.4123.62--
Sipai Health Technology Co, Ltd4.72bn-256.47m4.38bn3.10k--2.69--0.9266-0.3555-0.35556.682.301.6416.3311.841,643,110.00-8.59---13.95--8.80---5.24--1.92--0.0398--14.39--81.34------
Genky DrugStores Co Ltd8.56bn278.63m4.41bn1.75k15.552.058.290.5157194.27194.275,966.931,474.471.746.6951.56103,503,100.005.684.618.637.4020.3121.183.262.810.34992.800.41369.769.3212.257.778.8513.4214.87
Fangzhou Inc-92.88bn-92.88bn5.58bn515.00------------------------------------------------10.43--48.66------
MedPlus Health Services Ltd4.87bn56.70m6.91bn21.00k122.425.0627.551.425.465.46469.93132.131.943.51430.12--2.262.682.733.4821.9221.141.171.380.43221.350.3903--23.4219.8731.5740.5931.14--
Dashenlin Pharmaceutical Group Co Ltd25.34bn1.07bn14.36bn45.47k13.401.97--0.56680.94120.941222.416.411.093.8423.18557,261.804.996.5710.0712.6334.8737.514.585.540.61269.070.577245.6715.4522.5912.6317.0226.516.85
Data as of Jul 26 2024. Currency figures normalised to JZJ Chain Drugstore Corp's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

50.99%Per cent of shares held by top holders
HolderShares% Held
Rongtong Fund Management Co., Ltd.as of 31 Dec 202312.66m16.60%
Guotai Asset Management Co., Ltd.as of 31 Dec 20236.14m8.05%
Essence Fund Co., Ltd.as of 31 Dec 20235.49m7.20%
Zhong Ou Asset Management Co., Ltdas of 31 Dec 20234.58m6.01%
GF Fund Management Co., Ltd.as of 31 Dec 20232.70m3.54%
ICBC Credit Suisse Asset Management Co., Ltd.as of 31 Dec 20232.16m2.84%
China Southern Asset Management Co., Ltd.as of 31 Dec 20231.62m2.12%
Orient Securities Asset Management Co. Ltd.as of 31 Dec 20231.32m1.73%
Great Wall Fund Management Co., Ltd.as of 31 Dec 20231.17m1.54%
Penghua Fund Management Co., Ltd.as of 31 Dec 20231.04m1.37%
More ▼
Data from 31 Dec 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.